Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
April 24, 2024 16:51 ET
|
Ocean Biomedical, Inc.
PROVIDENCE, Rhode Island, April 24, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on April 18, 2024, it received a notice from The Nasdaq Stock Market...
Amedisys Reports First Quarter 2024 Financial Results
April 24, 2024 16:45 ET
|
Amedisys, Inc.
BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended...
CVB Financial Corp. Reports Earnings for the First Quarter 2024
April 24, 2024 16:45 ET
|
CVB Financial Corp
First Quarter 2024 Net Earnings of $48.6 million, or $0.35 per share Return on Average Assets of 1.21%Return on Average Tangible Common Equity of 15.13% Net Interest Margin of 3.10% ...
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024 16:45 ET
|
NKGen Biotech, Inc.
SANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and...
Riot Announces First Quarter 2024 Earnings Conference Call
April 24, 2024 16:45 ET
|
Riot Platforms, Inc
Castle Rock, CO, April 24, 2024 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), an industry leader in vertically integrated Bitcoin (“BTC”) mining, announced today...
NANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FINANCIERS POUR L’ANNÉE 2023
April 24, 2024 16:40 ET
|
Nanobiotix S.A.
L’accord de licence globale de co-développement et de commercialisation avec Janssen Pharmaceutica NV (« Janssen ») étend le potentiel du radioenhancer NBTXR3 à l’échelle internationale.La survie...
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
April 24, 2024 16:40 ET
|
Nanobiotix S.A.
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102...
Woodward Announces Declaration of Dividend
April 24, 2024 16:35 ET
|
Woodward, Inc.
Woodward Announces Declaration of Dividend
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024 16:35 ET
|
BioAtla, Inc.
SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody...
Mark Hutchinson Joins F&M Bank as Treasurer
April 24, 2024 16:31 ET
|
Farmers & Merchants Bancorp, Inc.
F&M Bank announced that Mark Hutchinson has joined the bank as Treasurer. He will oversee budgeting, planning, investing and other financial matters.